Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanisms of Action of Dimethyl Fumarate in Relapsing MS
NCT02675413Phase 4Withdrawn
- Sponsor
- Washington University School of Medicine
- Start
- Apr 2016
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dimethyl fumarate in multiple sclerosis (MS), sponsored by Washington University School of Medicine. Planned start Apr 2016; status: withdrawn.
02
Drugs
dimethyl fumarate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02675413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02675413.